Barclays has revised its price target for Keurig Dr Pepper (KDP, Financial), reducing it slightly from $38 to $37. Despite this adjustment, the financial institution maintains an Overweight rating on the company’s shares. This decision follows recent discussions with KDP's management, which prompted an update to the company’s performance model.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 18 analysts, the average target price for Keurig Dr Pepper Inc (KDP, Financial) is $39.02 with a high estimate of $44.00 and a low estimate of $34.00. The average target implies an upside of 18.09% from the current price of $33.04. More detailed estimate data can be found on the Keurig Dr Pepper Inc (KDP) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, Keurig Dr Pepper Inc's (KDP, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Keurig Dr Pepper Inc (KDP, Financial) in one year is $38.94, suggesting a upside of 17.86% from the current price of $33.04. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Keurig Dr Pepper Inc (KDP) Summary page.
